Review article · 2019 · Open access
A Review of Patient-Reported Outcomes Labeling for Oncology Drugs Approved by the FDA and the EMA (2012-2016)
Value in Health, 22(2), 203–209 · Published 30 January 2019 · DOI 10.1016/j.jval.2018.09.2842
In brief
“A Review of Patient-Reported Outcomes Labeling for Oncology Drugs Approved by the FDA and the EMA (2012-2016)” is a 2019 review article by Ari Gnanasakthy and 4 co-authors, published in Value in Health. OpenAlex counts 141 citations as of 22 November 2026. It is open access: the full text is free to read at Value in Health.
- Citations
- 141
- Most cited in
- 2024 (24)
- Field-weighted impact
- 3.69
- References
- 38
- Authors
- 5
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Gnanasakthy, A., Barrett, A. M., Evans, E., D’Alessio, D., & DeMuro, C. (2019). A Review of Patient-Reported Outcomes Labeling for Oncology Drugs Approved by the FDA and the EMA (2012-2016). Value in Health, 22(2), 203–209. https://doi.org/10.1016/j.jval.2018.09.2842
MLA 9
Gnanasakthy, Ari, et al. “A Review of Patient-Reported Outcomes Labeling for Oncology Drugs Approved by the FDA and the EMA (2012-2016).” Value in Health, vol. 22, no. 2, 2019, pp. 203–209. https://doi.org/10.1016/j.jval.2018.09.2842.
Chicago
Gnanasakthy, Ari, Amy M Barrett, Emily Evans, Denise D’Alessio, and Carla DeMuro. 2019. “A Review of Patient-Reported Outcomes Labeling for Oncology Drugs Approved by the FDA and the EMA (2012-2016).” Value in Health 22 (2): 203–209. https://doi.org/10.1016/j.jval.2018.09.2842.
Harvard
Gnanasakthy, A. et al. (2019) ‘A Review of Patient-Reported Outcomes Labeling for Oncology Drugs Approved by the FDA and the EMA (2012-2016)’, Value in Health, 22(2), pp. 203–209. doi:10.1016/j.jval.2018.09.2842.
IEEE
A. Gnanasakthy, A. M. Barrett, E. Evans, D. D’Alessio, and C. DeMuro, “A Review of Patient-Reported Outcomes Labeling for Oncology Drugs Approved by the FDA and the EMA (2012-2016),” Value in Health, vol. 22, no. 2, pp. 203–209, 2019, doi: 10.1016/j.jval.2018.09.2842.
BibTeX
@article{gnanasakthy2019review,
title = {{A Review of Patient-Reported Outcomes Labeling for Oncology Drugs Approved by the FDA and the EMA (2012-2016)}},
author = {Gnanasakthy, Ari and Barrett, Amy M and Evans, Emily and D’Alessio, Denise and DeMuro, Carla},
journal = {Value in Health},
year = {2019},
volume = {22},
number = {2},
pages = {203--209},
doi = {10.1016/j.jval.2018.09.2842},
url = {https://doi.org/10.1016/j.jval.2018.09.2842}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2013 | 1 | |
| 2019 | 7 | |
| 2020 | 16 | |
| 2021 | 23 | |
| 2022 | 18 | |
| 2023 | 21 | |
| 2024 | 24 | |
| 2025 | 13 | |
| 2026 | 17 |
Its field-weighted citation impact is 3.69: it has been cited 3.69 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- patient-reported outcomes
- drug labeling
- oncology drug approval
- FDA
- EMA
- regulatory standards
- Summary of Product Characteristics
- EORTC QLQ-C30
Work with this paper
Most-cited papers in Economics, Econometrics and Finance
- Theory of the firm: Managerial behavior, agency costs and ownership structureMichael C. Jensen, William H. Meckling · Journal of Financial Economics · 1976 · 77,585 citations
- Institutions, Institutional Change and Economic PerformanceDouglass C. North · Cambridge University Press eBooks · 1990 · 34,377 citations
- The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.John E. Ware, Cathy Donald Sherbourne · PubMed · 1992 · 33,943 citations
- Some Tests of Specification for Panel Data: Monte Carlo Evidence and an Application to Employment EquationsManuel Arellano, Stephen R. Bond · The Review of Economic Studies · 1991 · 33,778 citations
- Co-Integration and Error Correction: Representation, Estimation, and TestingRobert F. Engle, C.W.J. Granger · Econometrica · 1987 · 32,847 citations
Questions about this paper
How do I cite this paper in APA style?
Gnanasakthy, A., Barrett, A. M., Evans, E., D’Alessio, D., & DeMuro, C. (2019). A Review of Patient-Reported Outcomes Labeling for Oncology Drugs Approved by the FDA and the EMA (2012-2016). Value in Health, 22(2), 203–209. https://doi.org/10.1016/j.jval.2018.09.2842
How many times has this paper been cited?
141 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Value in Health: sign in and open the full text from this page.
Who wrote this paper?
Ari Gnanasakthy, Amy M Barrett, Emily Evans, Denise D’Alessio, Carla DeMuro.
What is the DOI of this paper?
10.1016/j.jval.2018.09.2842, permanently at https://doi.org/10.1016/j.jval.2018.09.2842. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.